MBS item numbers for chemotherapy services -changes to be implemented on 1 Nov 2020

 

 

Disclaimer: The material presented in this webinar was correct on 20 October 2020. Medicare law changes constantly and you should therefore seek independent legal advice before relying on specific legal content in this presentation after that date.
 
The PCPA leadership will continue to seek further clarity on the items that were not addressed during the webinar.

Date: Tuesday 20th October 2020 

Time: 8:00pm (AEDT)

In this webinar we covered:

1. The new, simplified MBS structure for chemotherapy procedures

  • All time-based item numbers to be replaced by single item number 13950 for administration of parenteral anti-neoplastic therapy, by or on behalf of a specialist or consultant physician.
  • Deletion of item number 13945
  • Modification to item number 14221

2. Impact to practices for oversight and management of therapeutic agents

3. Legal aspects of the MBS and principles of billing for cancer clinicians 

Click on below image to view a recording of the webinar. 

DOWNLOAD: Department of Health Information Release #4 MBS Chemotherapeutic Procedures Frequently Asked Questions. (PDF)

 

 

MBS item numbers in cancer care - Old and New

Disclaimer: The material presented in this webinar was correct on 21 May 2020. Medicare law changes constantly and you should therefore seek independent legal advice before relying on specific legal content in this presentation after that date.

Date: Thursday 21st May 2020

Time: 19:30 (AEST)

In this inaugural PCPA MBS billing webinar we covered:

  • Background to the MBS
  • Legal aspects of the MBS including bulk billing
  • Consultation items including telehealth.
  • Chemotherapy item numbers - principles of billing for cancer clinicians.

Click on below image to view a recording of the webinar. 

Date of Webinar: 
Tuesday, October 20, 2020 - 20:00
Name of Webinar: 
Webinar - Tuesday 20th October 2020
behalf of Australian cancer patients and their families
The ‘Cancer Care, No Gaps’ Journey. Clinical trials – more patients, less cost.
May 9, 2019
Private oncologists reject PM claims of ‘fee hikes’ for cancer patients
Enjoy all the benefits of membership
With a strong leadership group and a potential membership base of all private oncologists and haematologists, PCPA represents a critical group of specialists in the cancer care service spectrum.